Skip to content
Search for:
About us
Overview
History
Management Board
Ethical management
Areas of Partnership
Location
Core Technology
NexP™ Fusion Technology
NexMab™ ADC Technology
Biosimilars
Technological Outcomes
Pipeline
Overview
Project
ALT-P1
ALT-Q2
Project
ALT-P7
ALT-Q5
Project
ALT-L9
ALT-L2
ALT-LS2
ESG
ESG introduction
ESG introduction
ESG Goal
ESG Guide line
Environmental
Environmental management
Safety and Health management
Introduction
Social
Charter
Counseling Center
Consultation Application
Board of directors
Board of directors
Audit System
Compliance Management
Ethics Charter
IR
News
Reports
Notices
Career
Whom Alteogen is Looking for
Job Notice
로그인
한국어
Loading...
News
alteogen
2018-04-27T13:47:37+09:00
News
Reports
Notices
News
Number
Title
Author
Date
Notice
Alteogen Enters Into an Exclusive License Agreement to Develop and Commercialize Biosimilar Products
alteogen
|
2023.01.06
|
Votes 0
|
Views 1255
alteogen
2023.01.06
Notice
Alteogen Announces Completion of Phase 1 Clinical Trial of Aflibercept Biosimilar in Wet AMD Patients
alteogen
|
2023.01.06
|
Votes 0
|
Views 728
alteogen
2023.01.06
Notice
Alteogen Enters Into an Exclusive License Agreement With Intas to Develop and Commercialize Two Products
alteogen
|
2023.01.06
|
Votes 0
|
Views 711
alteogen
2023.01.06
Notice
Alteogen Enters into a Global License Agreement with a Top Ten Pharmaceutical Company for Use of Its Hybrozyme™ Technology
alteogen
|
2023.01.06
|
Votes 0
|
Views 799
alteogen
2023.01.06
Notice
Alteogen Enters into a Non-exclusive License Agreement with a Global Pharmaceutical Company for Use of Its Hybrozyme™Technology
alteogen
|
2023.01.06
|
Votes 0
|
Views 538
alteogen
2023.01.06
9
24 AUG 2016 Human Phase1 Clinical Data of ALT-P1 (hGH-NexP) by Healthy Korean Males
alteogen
|
2018.05.28
|
Votes 0
|
Views 629
alteogen
2018.05.28
8
2 MAR 2016 | Alteogen set to start phase I testing for Herceptin biosimilar
alteogen
|
2018.05.28
|
Votes 0
|
Views 774
alteogen
2018.05.28
7
12 OCT 2015 | Alteogen inks deal with 3Sbio for ADC targeting HER2
alteogen
|
2018.05.28
|
Votes 0
|
Views 703
alteogen
2018.05.28
6
13 JUL 2015 | The patent for long-acting recombinant Alpha-1 Antitrypsin (A1AT)
alteogen
|
2018.05.28
|
Votes 0
|
Views 664
alteogen
2018.05.28
5
30 MAR 2015 | The project with KISSEI has been progressing steadily
alteogen
|
2018.05.28
|
Votes 0
|
Views 620
alteogen
2018.05.28
4
12 DEC 2014 | ALTEOGEN is listed on KOSDAQ
alteogen
|
2018.05.28
|
Votes 0
|
Views 610
alteogen
2018.05.28
3
03 DEC 2014 | NexP™ fusion technology patent registry in EU
alteogen
|
2018.05.28
|
Votes 0
|
Views 603
alteogen
2018.05.28
2
18 AUG 2014 | NexP™ fusion technology patent registry in China
alteogen
|
2018.05.28
|
Votes 0
|
Views 585
alteogen
2018.05.28
1
12 FEB 2014 | ALTEOGEN starts collaboration in mAb biosimilar with KISSEI Pharma.
alteogen
|
2018.05.28
|
Votes 0
|
Views 705
alteogen
2018.05.28
First
«
1
2
3
All
Title
Content
Author
Search
Go to Top